Dean Tang

Professor & Chairperson

Roswell Park Comprehensive Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dean Tang is a Professor and Chairperson at Roswell Park Comprehensive Cancer Center in the United States. His research focuses on prostate cancer, particularly the mechanisms of metastasis, cancer stem cells, and cell heterogeneity. Recent publications include studies on neutrophil extracellular traps, single-cell analysis in castration-resistant prostate cancer, and the role of LRIG1 in tumor suppression.

Articles (7)

Year:

2025

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (3)

Rahul Kumar

Research Assistant Professor of Oncology

Roswell Park Comprehensive Cancer Center

UNITED STATES

View details

Qiang Hu

Roswell Park Comprehensive Cancer Center

UNITED STATES

View details

Michael Shen

Columbia University Irving Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Dean Tang

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver

Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells.

Prostate cancer as a dedifferentiated organ: androgen receptor, cancer stem cells, and cancer stemness

Understanding and targeting prostate cancer cell heterogeneity and plasticity

Slow-Cycling (Dormant) Cancer Cells in Therapy Resistance, Cancer Relapse and Metastasis.

LRIG1, a regulator of stem cell quiescence and a pleiotropic feedback tumor suppressor.

Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer

Collaborators (3)

Rahul Kumar

Qiang Hu

Michael Shen

Make your next move.